PT - JOURNAL ARTICLE AU - Hassouna, Habiba AU - Deshpande, Abhishek TI - Clinicians should assess the benefits and risks of using bezlotoxumab for reducing the risk of recurrent <em>Clostridium difficile</em> infection AID - 10.1136/ebmed-2017-110722 DP - 2017 Aug 01 TA - Evidence Based Medicine PG - 150--151 VI - 22 IP - 4 4099 - http://ebm.bmj.com/content/22/4/150.short 4100 - http://ebm.bmj.com/content/22/4/150.full SO - Evid Based Med2017 Aug 01; 22